Haixin Yu - Search Results

Year	Number of Results
2011	1
2012	1
2013	1
2014	1
2015	5
2016	2
2017	4
2018	3
2019	5
2020	2
2021	6
2022	15
2023	3
2024	6

1

TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks.

Ma J, Zhou Y, Pan P, Yu H, Wang Z, Li LL, Wang B, Yan Y, Pan Y, Ye Q, Liu T, Feng X, Xu S, Wang K, Wang X, Jian Y, Ma B, Fan Y, Gao Y, Huang H, Li L. Ma J, et al. Among authors: yu h. Nat Commun. 2023 Mar 31;14(1):1810. doi: 10.1038/s41467-023-37499-5. Nat Commun. 2023. PMID: 37002234 Free PMC article.

2

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.

Zhou Y, Jin X, Yu H, Qin G, Pan P, Zhao J, Chen T, Liang X, Sun Y, Wang B, Ren D, Zhu S, Wu H. Zhou Y, et al. Among authors: yu h. Theranostics. 2022 Jan 31;12(5):2080-2094. doi: 10.7150/thno.69444. eCollection 2022. Theranostics. 2022. PMID: 35265200 Free PMC article.

3

RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway.

Xiong W, Zhang B, Yu H, Zhu L, Yi L, Jin X. Xiong W, et al. Among authors: yu h. Adv Sci (Weinh). 2021 Sep;8(18):e2100881. doi: 10.1002/advs.202100881. Epub 2021 Jul 28. Adv Sci (Weinh). 2021. PMID: 34319001 Free PMC article.

4

Electrode materials for electrochromic supercapacitors.

Li J, Yu H, Lv Y, Cai Z, Shen Y, Ruhlmann L, Gan L, Liu M. Li J, et al. Among authors: yu h. Nanotechnology. 2024 Jan 23;35(15). doi: 10.1088/1361-6528/ad18e2. Nanotechnology. 2024. PMID: 38150723 Review.

5

CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression.

Zhang H, Yu H, Ren D, Sun Y, Guo F, Cai H, Zhou C, Zhou Y, Jin X, Wu H. Zhang H, et al. Among authors: yu h. Int J Biol Sci. 2022 May 13;18(8):3484-3497. doi: 10.7150/ijbs.68995. eCollection 2022. Int J Biol Sci. 2022. PMID: 35637952 Free PMC article.

6

The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer.

Yong L, Tang S, Yu H, Zhang H, Zhang Y, Wan Y, Cai F. Yong L, et al. Among authors: yu h. Front Oncol. 2022 Aug 8;12:964934. doi: 10.3389/fonc.2022.964934. eCollection 2022. Front Oncol. 2022. PMID: 36003773 Free PMC article. Review.

7

Asymmetric Total Synthesis of Pre-schisanartanin C.

Jiang YL, Yu HX, Li Y, Qu P, Han YX, Chen JH, Yang Z. Jiang YL, et al. J Am Chem Soc. 2020 Jan 8;142(1):573-580. doi: 10.1021/jacs.9b11872. Epub 2019 Dec 17. J Am Chem Soc. 2020. PMID: 31789517

8

Circulating microRNA biomarkers for lung cancer detection in Western populations.

Yu H, Guan Z, Cuk K, Brenner H, Zhang Y. Yu H, et al. Cancer Med. 2018 Oct;7(10):4849-4862. doi: 10.1002/cam4.1782. Epub 2018 Sep 27. Cancer Med. 2018. PMID: 30259714 Free PMC article. Review.

9

HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer.

Pan P, Qin G, Wang B, Yu H, Chen J, Liu J, Bing K, Shen J, Ren D, Zhao Y, Xia W, Li H, Wu H, Zhou Y. Pan P, et al. Among authors: yu h. Cancer Res. 2022 Dec 16;82(24):4542-4554. doi: 10.1158/0008-5472.CAN-21-4362. Cancer Res. 2022. PMID: 36102738 Free PMC article.

10

OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs.

Liu W, Yan B, Yu H, Ren J, Peng M, Zhu L, Wang Y, Jin X, Yi L. Liu W, et al. Among authors: yu h. Int J Biol Sci. 2022 Jan 24;18(4):1401-1414. doi: 10.7150/ijbs.68980. eCollection 2022. Int J Biol Sci. 2022. PMID: 35280681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

48 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year